TMDX Q3 2018 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

Q3 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4M+116.3% YoY

Gross Profit

$2M52.8% margin

Operating Income

-$4M-97.5% margin

Net Income

-$5M-126.4% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+38.6%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$31,000

Balance Sheet

Total Assets

$48M

Total Liabilities

$46M

Stockholders' Equity

$3M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+116.3%
Gross Profit	$2M	$485,000	+339.6%
Operating Income	-$4M	-$5M	+16.7%
Net Income	-$5M	-$5M	-6.2%